Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.

Abstract

The effective self-management of obstructive lung disease is dependent upon the patient achieving good inhaler technique. However, many current inhalers are complicated to use, which may lead to handling difficulties. These difficulties can cause clinically relevant errors, whereby pharmacotherapy fails to achieve adequate lung deposition and therapeutic effect. In this report, the potential of novel inhaler devices to overcome unmet needs in the management of obstructive lung disease is considered by a panel of Nordic experts. The panel concludes that innovative inhalers can contribute to good disease management and better use of healthcare resources.

• Authors: Anders Løkke, Lars Ahlbeck, Leif Bjermer, Jann Mortensen, Anders Østrem, Iris Pasternack, Guilherme Safioti, Saku Torvinen
• Journal: European clinical respiratory journal (Eur Clin Respir J) Vol. 2 Pg. 29445 ( 2015) ISSN: 2001-8525 [Print] United States
• PMID: 26689215 (Publication Type: Journal Article)